ONDA LIFEBio OS
[ HEAD-TO-HEAD ]

Flow Neuroscience vs Apollo Neuro (2026)

Flow Neuroscience and Apollo Neuro are two devices that look similar on a feature list — both wearable, both targeting mood and stress — but are not really the same kind of product. Flow is a CE-marked Class IIa medical device for major depression, delivering transcranial direct-current stimulation (tDCS) under a clinical protocol. Apollo Neuro is a vibrotactile wellness wearable that modulates vagal tone without a clinical indication. Different categories, often compared.

VERDICT: TIE

Not really substitutes. Flow Neuroscience for clinical-grade tDCS depression treatment under a structured programme. Apollo Neuro for all-day vibrotactile vagal modulation in general wellness use.

Flow Neuroscience6.7 / 10

Flow Neuroscience

CE-marked tDCS headset (depression, prescribed in some markets)

Not EEG — clinical tDCS for depression, with the strongest regulatory and trial backing in this list.

Apollo Neuroscience7.5 / 10

Apollo Neuro

Vibrotactile vagal modulator (wearable)

The most wearable device in the category — vibrotactile, not electrical, with mounting clinical evidence on HRV and recovery.

Head-to-head breakdown

  • Regulatory status

    Flow Neuroscience: CE-marked Class IIa medical device. Apollo Neuro: consumer wellness wearable, no medical-device clearance. Flow is the regulated option.

    Flow Neuroscience

  • Mechanism

    Flow: tDCS — 2 mA direct-current stimulation over the dorsolateral prefrontal cortex (active intervention). Apollo: vibrotactile, indirect vagal modulation via mechanoreceptors. Flow is more direct.

    Flow Neuroscience

  • Indication scope

    Flow: indicated only for major depression. Apollo: general wellness — recovery, focus, sleep, calm. Apollo is broader-use; Flow is narrower by design.

    Apollo Neuro

  • Clinical evidence

    Flow: published RCTs in Lancet Digital Health and Brain Stimulation for tDCS in major depression. Apollo: University of Pittsburgh HRV/recovery RCTs. Both real; Flow is clinical-grade.

    Flow Neuroscience

  • Day-to-day use frequency

    Apollo: continuous daily wear. Flow: 30-minute structured sessions in an 8-week programme. Apollo runs in the background; Flow is foreground intervention.

    Apollo Neuro

  • Wearability

    Apollo: wrist/ankle/clip-on for 24/7 wear. Flow: rigid headset for seated sessions only. Apollo wins on daily life integration.

    Apollo Neuro

  • Programme structure

    Flow: structured 8-week behavioural-therapy programme combined with stimulation. Apollo: open-ended mode selection. Flow has the clinical scaffolding.

    Flow Neuroscience

  • Price

    Apollo: $349 + optional $15/mo. Flow: £399 (~$499) + monthly therapy-app subscription. Apollo is cheaper with no required subscription.

    Apollo Neuro

Choose Flow Neuroscience

Choose Flow Neuroscience if you have major depression and a clinician open to a CE-marked tDCS option — the strongest regulatory and trial backing in take-home brain devices.

Choose Apollo Neuro

Choose Apollo Neuro if you want passive vagal modulation through your day — general wellness, recovery, stress — without a clinical indication or programme commitment.

The short version

Flow Neuroscience and Apollo Neuro look adjacent but are not really substitutes. Flow is a CE-marked clinical device for diagnosed major depression; Apollo is a consumer wellness wearable for general vagal modulation. The decision is whether you have a clinical condition or a wellness intent.

When Flow Neuroscience is the right pick

If you have major depression and a clinician open to discussing tDCS as a take-home option, Flow is the right shape. The CE-marked regulatory status, the published trial base in Lancet Digital Health, and the structured 8-week behavioural-therapy programme are the value. For general wellness this is the wrong tool — the indication is narrow on purpose.

When Apollo Neuro is the right pick

If you want passive vagal modulation through the day — for recovery, stress, sleep, focus — without a clinical indication or a structured programme commitment, Apollo is the right shape. The vibrotactile mechanism is real; the University of Pittsburgh research base is solid; daily wearability is the use case.

Common questions

Should I pick Flow Neuroscience or Apollo Neuro?

They solve different problems. Flow if you have major depression and a clinician open to tDCS as a take-home option — Flow is the only CE-marked tDCS device with a structured behavioural-therapy programme. Apollo if you want general wellness vagal modulation throughout the day without a clinical indication.

Is Flow Neuroscience FDA-approved?

No — Flow is CE-marked in Europe as a Class IIa medical device and prescribed within parts of the UK NHS. In the US it is not FDA-approved for any indication. Apollo Neuro is sold as a consumer wellness device, also without FDA clearance.

Can I treat my own depression with Apollo Neuro?

Apollo Neuro is not indicated for any clinical condition. For diagnosed depression, Flow Neuroscience is the regulated option; Apollo is for wellness use only. The two should not be conflated.

Should I use both?

In theory the mechanisms (active tDCS vs passive vibrotactile) don’t overlap. In practice, if you have clinical depression Flow is the right tool under medical guidance; Apollo is for general wellness alongside it. The combination is unusual.

See the full ranking

Best Vagus Nerve Stimulators (2026)

ONDA ranks the ten best vagus nerve stimulators of 2026 — auricular tVNS, cervical tVNS, vibrotactile, infrasonic and one implanted reference. Scored on evidence, mechanism, protocols and value.

→